Department of Biopharmaceutical Science, College of Pharmaceutical Sciences, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou, 310014, China.
Int J Biol Sci. 2013 May 8;9(5):435-43. doi: 10.7150/ijbs.6087. Print 2013.
As an important member of tyrosine kinase family, c-kit receptor causes specific expression of certain genes, regulates cell differentiation and proliferation, resists cell apoptosis, and plays a key role in tumor occurrence, development, migration and recurrence through activating the downstream signaling molecules following interaction with stem cell factor (SCF). The abnormality of SCF/c-kit signaling pathway is closely related to some certain tumors. The discovery of c-kit receptor-targeted drugs has promoted clinical-related cancer's diagnosis and treatment. In this paper, we review recent research progress on c-kit receptor-mediated signal transduction and its potential therapeutic application as a target in tumor-related diseases.
作为酪氨酸激酶家族的重要成员,c-kit 受体通过与干细胞因子(SCF)相互作用激活下游信号分子,引起特定基因的特异性表达,调节细胞分化和增殖,抵抗细胞凋亡,在肿瘤的发生、发展、迁移和复发中发挥关键作用。SCF/c-kit 信号通路的异常与某些肿瘤密切相关。c-kit 受体靶向药物的发现促进了临床相关癌症的诊断和治疗。本文就 c-kit 受体介导的信号转导及其作为肿瘤相关疾病治疗靶点的潜在治疗应用的最新研究进展作一综述。